Señales en vivo de PROB.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 may 2024 @ 04:59):

Stats
Volumen de hoy	334.00
Volumen promedio	659.00
Capitalización de mercado	2.32B
EPS	SEK0 ( 2024-04-23 )
Próxima fecha de ganancias	( SEK0 ) 2024-07-16
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	137.84
ATR14	SEK0 (0.00%)

Probi AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Probi AB (publ) Finanzas

Annual	2023
Ingresos:	SEK627.69M
Beneficio Bruto:	SEK220.21M (35.08 %)
EPS:	SEK1.480

FY	2023
Ingresos:	SEK627.69M
Beneficio Bruto:	SEK220.21M (35.08 %)
EPS:	SEK1.480

FY	2022
Ingresos:	SEK618.29M
Beneficio Bruto:	SEK255.45M (41.32 %)
EPS:	SEK3.57

FY	2021
Ingresos:	SEK658.18M
Beneficio Bruto:	SEK288.01M (43.76 %)
EPS:	SEK7.30

Financial Reports:

No articles found.

Probi AB (publ)

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.